Descriptor
Renovo is a biopharmaceutical product company and a leader in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration.
History
Founded in 1998, Renovo commenced operations in October 2000 and floated on the main market of the London Stock Exchange in April 2006. Since 24 October 2011 the company has traded on the London AIM market.
Founding team
Professor Mark Ferguson and Dr Sharon O’Kane
Head Office
The Manchester Incubator Building
48 Grafton Street
Manchester, M13 9XX
United Kingdom
E-mail: queries@renovo.com
Printer-friendly version